Phost'in Therapeutics Revenue

Biotechnology Research • Montpellier, Occitanie, France • 11-20 Employees

Phost'in Therapeutics revenue & valuation

Annual revenue	$1,283,325
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$4,200,000
Total funding	No funding

Key Contacts at Phost'in Therapeutics

David Virieux

Co Founder - Chemistry Expert

Karine Chorro

Ceo And Co-Founder At

Ludovic Clarion

R&D Director And Co-Founder

Company overview

Headquarters	104, Rue de la Galera, Montpellier, Occitanie 34090, FR
Website	phostin.com
NAICS	541714
Keywords	Glyco Immuno Oncology
Employees	11-20

Phost'in Therapeutics Email Formats

Phost'in Therapeutics uses 2 email formats. The most common is {first name}.{last name} (e.g., john.doe@phostin.com), used 52.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@phostin.com	52.9%
{first initial}.{last name}	j.doe@phostin.com	47.1%

About Phost'in Therapeutics

Phost’in Therapeutics discovers and develops First-In-Class Glycocalyx Modifiers for selective treatment of cancers and other serious diseases. A new and innovative player in the field of Glyco-Immuno-Oncology, Phost’in Therapeutics develops a class of highly potent anti-cancer NCEs (new chemical entities) targeting a key glycosylation mechanism responsible for suppressing the immune response. Our first generation of Glycosylation inhibitors aims to unblock immune response and down-modulate invasiveness for the treatment of aggressive solid tumors.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

C-Suite

Manager

Entry

Employees by Department

Phost'in Therapeutics has 9 employees across 7 departments.

Departments

Number of employees

Funding Data

Phost'in Therapeutics has never raised funding before.

Frequently asked questions

Phost'in Therapeutics is located in Montpellier, Occitanie, FR.

Phost'in Therapeutics generates an estimated annual revenue of $1,283,325. This revenue figure reflects the company's market position and business performance in its industry.

Phost'in Therapeutics has an estimated valuation of $4,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Phost'in Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.